NO912942L - Vaksine for preventiv behandling av infeksjon av leverikte hos droevtyggere. - Google Patents
Vaksine for preventiv behandling av infeksjon av leverikte hos droevtyggere.Info
- Publication number
- NO912942L NO912942L NO91912942A NO912942A NO912942L NO 912942 L NO912942 L NO 912942L NO 91912942 A NO91912942 A NO 91912942A NO 912942 A NO912942 A NO 912942A NO 912942 L NO912942 L NO 912942L
- Authority
- NO
- Norway
- Prior art keywords
- vaccine
- infection
- liverability
- drugs
- preventive treatment
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 title 1
- 230000003449 preventive effect Effects 0.000 title 1
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 241000123208 Fistulina hepatica Species 0.000 abstract 1
- 102000005720 Glutathione transferase Human genes 0.000 abstract 1
- 108010070675 Glutathione transferase Proteins 0.000 abstract 1
- 206010056522 Hepatic infection Diseases 0.000 abstract 1
- 108020004511 Recombinant DNA Proteins 0.000 abstract 1
- 241000282849 Ruminantia Species 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
- C12N9/1088—Glutathione transferase (2.5.1.18)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPJ248189 | 1989-01-31 | ||
| PCT/AU1990/000027 WO1990008819A1 (en) | 1989-01-31 | 1990-01-31 | Vaccine for the preventative treatment of infection of liver fluke in ruminants |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO912942D0 NO912942D0 (no) | 1991-07-29 |
| NO912942L true NO912942L (no) | 1991-09-26 |
Family
ID=3773671
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO91912942A NO912942L (no) | 1989-01-31 | 1991-07-29 | Vaksine for preventiv behandling av infeksjon av leverikte hos droevtyggere. |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0456662A4 (pt) |
| JP (1) | JPH04507235A (pt) |
| AU (1) | AU634754B2 (pt) |
| BR (1) | BR9007070A (pt) |
| CA (1) | CA2045663A1 (pt) |
| NO (1) | NO912942L (pt) |
| NZ (1) | NZ232327A (pt) |
| WO (1) | WO1990008819A1 (pt) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2657883A1 (pt) * | 1990-02-07 | 1991-08-09 | Transgene Sa | |
| GB9018238D0 (en) * | 1990-08-20 | 1990-10-03 | Trudgett Alan G | Liver fluke diagnostic system |
| PT666919E (pt) * | 1992-10-21 | 2003-09-30 | John Pius Dalton | Vacina contendo uma protease de tiol |
| CA2126455A1 (en) * | 1993-02-05 | 1994-08-06 | Andrew R. Milner | Liver fluke vaccine and polypeptides useful for same |
| FI961392A0 (fi) * | 1993-09-28 | 1996-03-27 | Univ Melbourne | Suojaavia antigeeneja loisia vastaan |
| CN1061990C (zh) * | 1994-06-08 | 2001-02-14 | 北京医科大学 | 新型血吸虫疫苗肽(一) |
| CN1061991C (zh) * | 1994-06-08 | 2001-02-14 | 北京医科大学 | 新型血吸虫疫苗肽(三) |
| CN1068334C (zh) * | 1994-06-08 | 2001-07-11 | 北京医科大学 | 新型血吸虫疫苗肽(二) |
| GB9612214D0 (en) * | 1996-06-11 | 1996-08-14 | Mallinckrodt Veterinary Inc | Vaccine |
| CN105903007A (zh) * | 2016-06-15 | 2016-08-31 | 青海大学 | 一种新型肝片吸虫多表位疫苗的设计、制备方法和应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8432401D0 (en) * | 1984-12-21 | 1985-02-06 | Bennett C E | Liver fluke antigens |
| NZ224663A (en) * | 1987-05-28 | 1990-11-27 | Amrad Corp Ltd | Fusion proteins containing glutathione-s-transferase and expression of foreign polypeptides using glutathione-s-transferase encoding vectors |
-
1990
- 1990-01-31 BR BR909007070A patent/BR9007070A/pt not_active Application Discontinuation
- 1990-01-31 EP EP19900902123 patent/EP0456662A4/en not_active Ceased
- 1990-01-31 JP JP2502498A patent/JPH04507235A/ja active Pending
- 1990-01-31 WO PCT/AU1990/000027 patent/WO1990008819A1/en not_active Ceased
- 1990-01-31 CA CA002045663A patent/CA2045663A1/en not_active Abandoned
- 1990-01-31 AU AU50283/90A patent/AU634754B2/en not_active Ceased
- 1990-01-31 NZ NZ232327A patent/NZ232327A/en unknown
-
1991
- 1991-07-29 NO NO91912942A patent/NO912942L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ232327A (en) | 1993-02-25 |
| WO1990008819A1 (en) | 1990-08-09 |
| NO912942D0 (no) | 1991-07-29 |
| EP0456662A4 (en) | 1991-12-11 |
| CA2045663A1 (en) | 1990-08-01 |
| AU5028390A (en) | 1990-08-24 |
| AU634754B2 (en) | 1993-03-04 |
| BR9007070A (pt) | 1991-11-12 |
| EP0456662A1 (en) | 1991-11-21 |
| JPH04507235A (ja) | 1992-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Youn et al. | Beneficial effects of rosmarinic acid on suppression of collagen induced arthritis. | |
| ATE126706T1 (de) | Hauttest und testkit für aids. | |
| NO912942L (no) | Vaksine for preventiv behandling av infeksjon av leverikte hos droevtyggere. | |
| DE68907679D1 (de) | Sauerwiderstehender fibroblast-wachstumsfaktor, zubereitung zur behandlung von magen-darmweg-geschwuerkrankheiten. | |
| FI882707A7 (fi) | Menetelmä ja valmiste maidon proteiinipitoisuuden lisäämiseksi. | |
| ATE179614T1 (de) | Herpes simplex virus vp16 impfstoffe | |
| DE69628844D1 (de) | Leishmania-antigene zur anwendung in der leishmaniasis therapie und diagnose | |
| ATE130198T1 (de) | Herstellung eines virus und reinigung von virenüberzugsproteinen zur impfstoffverwendung. | |
| ATE222930T1 (de) | Antigene arznei zur behandlung oder vorbeugung | |
| IL105119A0 (en) | Immunoglobins and antigens for the treatment of staphylococcus infections,methods for the identification and preparation thereof and pharmaceutical compositions containing the same | |
| PT868522E (pt) | Virus recombinante de poxvirus - virus da peritonite infecciosa felina, suas composicoes e metodos para a sua preparacao e utilizacao | |
| EA199800526A1 (ru) | Производные бензимидазола и их применение для лечения вирусных инфекций | |
| DE3751772D1 (de) | Impfstoff zur behandlung von hsv | |
| DK0484438T3 (da) | Biologisk præparat og dets anvendelse | |
| ES2044170T3 (es) | Sal de estroncio, su procedimiento de preparacion y las composiciones farmaceuticas que la contienen. | |
| DE3750886D1 (de) | Verwendung eines immunglobulinhaltigen Präparates zur Prophylaxe und Therapie von AIDS beim Menschen. | |
| EP0251460A3 (en) | Method for producing hepatitis b virus core antigen (hbcag) in yeast | |
| Tu et al. | Comparison of Naja naja siamensis and Naja naja atra venoms | |
| ES8303916A1 (es) | "un metodo para preparar el antigeno de superficie de la hepatitis b puro a partir de plasma humano". | |
| DE3784513D1 (de) | Menschlicher b-lymphotroper virus (hblv), isolierung und erzeugnisse. | |
| Gerenčer et al. | Immunosuppression of in vivo and in vitro lymphocyte responses in swine induced by Trichinella spiralis or excretory-secretory antigens of the parasite | |
| DE69030181D1 (de) | Verwendung von cromakalim/brl 38227 zur behandlung der überreaktivität der luftwege | |
| Sun et al. | Effect of selenium in recovery of immunity damaged by H2O2 and60Co radiation | |
| RU2033181C1 (ru) | Средство для химиопрофилактики описторхоза | |
| ATE27822T1 (de) | Hexapeptid, verfahren zur herstellung und pharmazeutische zusammensetzungen hieraus. |